Celon Pharma S.A. (WSE:CLN)
21.80
-0.20 (-0.91%)
Oct 24, 2025, 5:03 PM CET
Celon Pharma Revenue
Celon Pharma had revenue of 55.82M PLN in the quarter ending June 30, 2025, a decrease of -14.94%. This brings the company's revenue in the last twelve months to 206.22M, down -0.78% year-over-year. In the year 2024, Celon Pharma had annual revenue of 205.55M, down -4.25%.
Revenue (ttm)
206.22M
Revenue Growth
-0.78%
P/S Ratio
5.69
Revenue / Employee
363.05K
Employees
558
Market Cap
1.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 205.55M | -9.12M | -4.25% |
| Dec 31, 2023 | 214.66M | 20.78M | 10.72% |
| Dec 31, 2022 | 193.89M | -2.20M | -1.12% |
| Dec 31, 2021 | 196.09M | 38.64M | 24.54% |
| Dec 31, 2020 | 157.45M | 55.20M | 53.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.04B |
| Diagnostyka | 2.17B |
| Centrum Medyczne ENEL-MED | 789.78M |
| Synektik Spólka Akcyjna | 623.20M |
| Mercator Medical | 579.83M |
| Voxel | 560.38M |
| Selvita | 373.90M |
| BIOTON | 265.14M |
Celon Pharma News
- 8 months ago - Strong Proof-of-Concept Data from Phase 2 Trial of PDE10A Inhibitor (CPL'36), a Novel Once-Daily Treatment of Levodopa-Induced Dyskinesia in Parkinson's Disease - Benzinga